Structured Review

Themis Bioscience chikungunya virus
Chikungunya Virus, supplied by Themis Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chikungunya virus/product/Themis Bioscience
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
chikungunya virus - by Bioz Stars, 2021-05
86/100 stars

Images

Related Articles

other:

Article Title: Human Vaccines & Immunotherapeutics: News
Article Snippet: A vaccine against the Chikungunya virus (Themis Bioscience) is being tested for optimal dose in a Phase 2 study.

Article Title: CEPI: Driving Progress Toward Epidemic Preparedness and Response
Article Snippet: Some of these technologies are established and already being tested in the clinic, such as a measles-vector–based vaccine against chikungunya developed by Themis Bioscience (Vienna, Austria) ( ); an attenuated virus vaccine against chikungunya developed by Valneva (Vienna, Austria) ( ); a DNA-based vaccine against Lassa virus ( ) and MERS-CoV, being developed by Inovio Pharmaceuticals (Plymouth Meeting, PA) ( ); and an adenovirus-vector–based vaccine against MERS-CoV, being developed by the University of Oxford (Oxford, United Kingdom) ( ).

Article Title: Measles-derived vaccines to prevent emerging viral diseases
Article Snippet: The MV-CHIKV vaccine candidate was further introduced into clinical trials by Themis Bioscience ( http://themisbio.com ).

Article Title: Recent development in the strategies projected for chikungunya vaccine in humans
Article Snippet: NCT03028441) has started recruiting healthy adults aged 18–45 years (n=180) to evaluate the safety, immunogenicity, and schedule of live-attenuated, measles-vectored CHIKV vaccine (MV-CHIKV) developed by Themis Bioscience GmbH.

Article Title: Recent development in the strategies projected for chikungunya vaccine in humans
Article Snippet: A Phase I/II, double blinded, placebo-controlled, dose comparison trial ( ClinicalTrials.gov NCT03028441) has started recruiting healthy adults aged 18–45 years (n=180) to evaluate the safety, immunogenicity, and schedule of live-attenuated, measles-vectored CHIKV vaccine (MV-CHIKV) developed by Themis Bioscience GmbH.

Article Title: Measles-derived vaccines to prevent emerging viral diseases.
Article Snippet: The MV-CHIKV vaccine candidate was further introduced into clinical trials by Themis Bioscience (http://themisbio. com).

Plasmid Preparation:

Article Title: Epidemiology of Chikungunya fever outbreak in Western Jamaica during July–December 2014
Article Snippet: .. A CHIKV virus-like particle (VLP) vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID), USA, is currently in phase 2 clinical trial, and a measles vector CHIKV vaccine developed by Themis Bioscience GmbH/Institut Pasteur is slated for phase 2 trials in 2016. , In low- and middle-income countries (LMIC) such as Jamaica where CHIKV has now become endemic, a licensed CHIKV vaccine would be useful during an outbreak, in vaccination campaigns, or as part of the standard immunization schedule. ..

Article Title: SARS-CoV-2 vaccine development and how Brazil is contributing
Article Snippet: .. Themis Bioscience is investigating the use of attenuated measles virus as a vaccine vector for chikungunya. ..

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Themis Bioscience measles vectored chikv vaccine mv chikv
    Measles Vectored Chikv Vaccine Mv Chikv, supplied by Themis Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/measles vectored chikv vaccine mv chikv/product/Themis Bioscience
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    measles vectored chikv vaccine mv chikv - by Bioz Stars, 2021-05
    86/100 stars
      Buy from Supplier

    86
    Themis Bioscience chikungunya virus
    Chikungunya Virus, supplied by Themis Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chikungunya virus/product/Themis Bioscience
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    chikungunya virus - by Bioz Stars, 2021-05
    86/100 stars
      Buy from Supplier

    Image Search Results